Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression

It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical trials. Although eight distinct PI3K isoforms exist, grouped into three classes, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chikh, Anissa, Ferro, Riccardo, Abbott, Jonathan J., Piñeiro, Roberto, Buus, Richard, Iezzi, Manuela, Ricci, Francesca, Bergamaschi, Daniele, Ostano, Paola, Chiorino, Giovanna, Lattanzio, Rossano, Broggini, Massimo, Piantelli, Mauro, Maffucci, Tania, Falasca, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951291/
https://www.ncbi.nlm.nih.gov/pubmed/26934321
http://dx.doi.org/10.18632/oncotarget.7761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951291/
https://www.ncbi.nlm.nih.gov/pubmed/26934321
http://dx.doi.org/10.18632/oncotarget.7761

Ejemplares similares